抑制新型AXL剪接变体AXL3可诱导套细胞淋巴瘤细胞凋亡
本研究在套细胞淋巴瘤(MCL)细胞中鉴定出酪氨酸激酶受体AXL的新型剪接变体AXL3,其缺乏配体结合域且呈组成性激活;CRISPR抑制实验显示仅敲低AXL3即可诱导MCL细胞凋亡,药理学抑制AXL可降低β-联蛋白、AKT和NF-κB等促增殖与生存通路的激活;MCL异种移植小鼠模型预临床研究显示,贝姆替尼(bemcentinib)在减少肿瘤负荷和延长总生存方面优于依鲁替尼。
要点
- 在MCL细胞中鉴定出缺乏配体结合域且组成性激活的新型AXL剪接变体AXL3。
- CRISPR抑制实验显示仅敲低AXL3即可诱导MCL细胞凋亡。
- MCL异种移植小鼠模型预临床研究显示贝姆替尼减少肿瘤负荷和延长总生存优于依鲁替尼。
核心结论
- 本研究突显了此前未鉴定的AXL剪接变体在癌症中的重要性,以及贝姆替尼作为MCL靶向治疗的潜力。
研究设计与样本
- 研究在MCL细胞中鉴定并表达新型AXL剪接变体AXL3,采用CRISPR抑制进行功能表征,并使用MCL异种移植小鼠模型进行预临床研究。
主要发现
- AXL3缺乏常见AXL剪接变体的配体结合域,并在MCL细胞中组成性激活。
- 使用CRISPR抑制进行功能表征显示,仅敲低AXL3即可导致MCL细胞凋亡。
- 药理学抑制AXL活性导致MCL细胞中β-联蛋白、Ak strain transforming和NF-κB等促增殖与生存通路的激活显著降低。
- MCL异种移植小鼠模型的预临床研究显示,贝姆替尼在减少肿瘤负荷和延长总生存方面比依鲁替尼更有效。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma having a poor overall survival that is in need for the development of new therapeutics. In this study, we report the identification and expression of a new isoform splice variant of the tyrosine kinase receptor AXL in MCL cells. This new AXL isoform, called AXL3, lacks the ligand-binding domain of the commonly described AXL splice variants and is constitutively activated in MCL cells. Interestingly, functional characterization of AXL3, using CRISPR inhibition, revealed that only the knock down of this isoform leads to apoptosis of MCL cells. Importantly, pharmacological inhibition of AXL activity resulted in a significant decrease in the activation of well-known proproliferative and survival pathways activated in MCL cells (ie, β-catenin, Ak strain transforming, and NF-κB). Therapeutically, preclinical studies using a xenograft mouse model of MCL indicated that bemcentinib is more effective than ibrutinib in reducing the tumor burden and to increase the overall survival. Our study highlights the importance of a previously unidentified AXL splice variant in cancer and the potential of bemcentinib as a targeted therapy for MCL.
引用
- Gelebart P, Eriksen Gjerstad M, Benjaminsen S, et al. Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells. Blood. 2023. PMID: 37339584. doi:10.1182/blood.2022015581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。